Prestige BioPharma
Latest round
- Series B
Last raised
- Oct 2019
Total raised
- $114M
Investors
- 4
About Prestige BioPharma
Founded in 2015 and based in Singapore, Prestige BioPharma Ltd is a biopharmaceutical company that develops antibody therapeutics and biosimilars for treating tumors and immune disorders.
Who invested in Prestige BioPharma
4 investors across 2 rounds
See all investors in Prestige BioPharma
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Prestige BioPharma
Who invested in Prestige BioPharma?
Prestige BioPharma has 4 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Prestige BioPharma raised?
Prestige BioPharma has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Prestige BioPharma last raise money?
Prestige BioPharma's most recent round on record is a Series B, in Oct 2019.
What does Prestige BioPharma do?
Founded in 2015 and based in Singapore, Prestige BioPharma Ltd is a biopharmaceutical company that develops antibody therapeutics and biosimilars for treating tumors and immune disorders.
Where is Prestige BioPharma headquartered?
Prestige BioPharma is headquartered in Singapore.
Which VCs invest in companies like Prestige BioPharma?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Prestige BioPharma's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Prestige BioPharma? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.